Juan Cubillos-Ruiz: Iron chelation therapy unleashes innate immune responses that control Ovarian Cancer
Juan Cubillos-Ruiz, Associate Professor for Infection and Immunology at Well Corner Medicine, shared on X:
“Our new study, published today in Cancer Discovery, reveals that iron chelation therapy unleashes innate immune responses that control Ovarian Cancer. Congrats to first author Tito Sandoval and the whole team.
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
Autors: Tito A. Sandoval, Camilla Salvagno, Chang-Suk Chae, Deepika Awasthi, Paolo Giovanelli, Matias Marin Falco, Sung-Min Hwang, Eli Teran-Cabanillas, Lasse Suominen, Takahiro Yamazaki, Hui-Hsuan Kuo, Jenna E. Moyer, M. Laura Martin, Jyothi Manohar, Kihwan Kim, Maria A. Sierra, Yusibeska Ramos, Chen Tan, Alexander Emmanuelli, Minkyung Song, Diana K. Morales, Dmitriy Zamarin, Melissa K. Frey, Evelyn Cantillo, Eloise Chapman-Davis, Kevin Holcomb, Christopher E. Mason, Lorenzo Galluzzi, Zhen Ni Zhou, Anna Vaharautio, Suzanne M. Cloonan, Juan R. Cubillos-Ruiz
Huge thanks to our fantastic collaborators Suzanne Cloonan and Anna Vähärautio for their major contributions to this study. We are also very grateful to the US Department of Defense OCRP for supporting this work since its inception.”
Source: Juan Cubillos-Ruiz/X